FR
Fennec Pharma
FRX.TO·TSXResearch Triangle NCFounded 200430 employees
Micro CapbiotechPublicOncology
Platform: Pedmark Cisplatin
Market Cap
$0.1B
All Drugs
2
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (FRX.TO)
Loading FRX.TO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kematinib | FRX-7728 | Phase 3 | 3 | WRN | FTDRSV | ||
| FRX-2080 | FRX-2080 | Phase 2/3 | 2 | PD-1 | Alzheimer's |
SEC Filings & Financial Documents
SEC filings are not available for TSX-listed companies.
Fennec Pharma trades on TSX (US). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)